课题基金 / 基金详情

Enzymic synthesis of complex carbohydrates using evolved enzymes

Enzymic synthesis of complex carbohydrates using evolved enzymes
使用进化酶酶法合成复杂碳水化合物
批准号:
BB/E000622/1
负责人:
Alan Berry
金额:
$69.89万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2007
资助国家:
英国
项目状态:
已结题
起止时间:
2007 至 --

项目摘要

项目成果

Alan Berry的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Mammalian cells are coated with a vast range of sugar molecules that play important roles in processes ranging from the infection of cells by invading bacteria and viruses, and how the immune system deals with these attacks, to how various cells communicate with each other. Such communication plays vital roles in normal development as well as being affected during disease states such as cancer. There is a growing need to be able to synthesise such sugar molecules for research in a wide range of areas, but complex sugars cannot be cloned, and their chemical synthesis is complicated because of the complex three-dimensional shapes of the molecules themselves. Synthetic chemists have developed routes to some sugar analogues, but these procedures are difficult and not very efficent. Nature's catalysts, the enzymes, carry out such reactions with great precision and efficiency, but their use by man in making complex sugars is limited because the enzymes have evolved to carry out specific reactions, which are not always those that the chemist wishes to carry out. This is particularly true when we wish to make unnatural mimics of the natural sugar. Fortunately, a method of engineering or evolving new, desired enzyme activities in the test-tube is available, and this application seeks funds to use this methodology to alter the properties of two natural enzymes to allow them to carry out the reactions that we want, and to allow them to be used to synthesise the novel complex sugars that we wish. We have already targetted one enzyme, called NAL, to alter its function to make new simple sugars, and have proved the basis of the methodology proposed. Now we will alter two different enzymes (called CNS and ST) to use our new simple sugars to be incoporated into mimics of the complex sugars that are found on the outsides of our cells.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1111/j.1742-4658.2010.07696.x
发表时间: 2010-07
期刊: The FEBS journal
影响因子: --
作者: [Horsfall LE, Nelson A, Berry A]
通讯作者: Berry A
DOI: 10.1016/j.abb.2008.01.005
发表时间: 2008-06-15
期刊: Archives of biochemistry and biophysics
影响因子: 3.9
作者: [Bolt A, Berry A, Nelson A]
通讯作者: Nelson A
Exploiting the distinctive catalysis of chemically modified enzymes
  • 批准号:
    BB/N002091/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $61.1万
  • 财政年份:
    2016
  • 负责人:
    Alan Berry
  • 依托单位:
国内基金
海外基金
胆固醇合成蛋白CYP51介导线粒体通透性转换诱发Th17/Treg细胞稳态失衡在舍格伦综合征中的作用机制研究
  • 批准号:
    82370976
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    郑凌艳
  • 依托单位:
“肠—肝轴”PPARα/CYP8B1胆汁酸合成信号通路在减重手术改善糖脂代谢中的作用与机制
  • 批准号:
    82370902
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    田景琰
  • 依托单位:
lncGEI诱导湖羊卵巢颗粒细胞E2合成的分子机制
  • 批准号:
    32372856
  • 项目类别:
    面上项目
  • 资助金额:
    50.00万元
  • 批准年份:
    2023
  • 负责人:
    李隐侠
  • 依托单位:
脂肪酸合成通过GDF15/IRS2介导胰岛素抵抗促进血管内皮细胞活化导致脓毒症肺损伤的机制研究
  • 批准号:
    82372203
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    李然然
  • 依托单位: